PATENT CLAIM ANALYSIS

Application Number: 16125991
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "380000"]

Abstract:
In one aspect, the invention relates to a crystalline form of the structure: or a pharmaceutically acceptable salt thereof, having neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising this crystalline form; methods of using this crystalline form and its soluble form (I); and processes for preparing soluble (I) and crystalline (I′) forms.

Claim (Index 38):
The crystalline form of  claim 17 ,  20  or  22 , wherein the crystalline form is characterized by a powder x-ray diffraction pattern comprising diffraction peaks at 2\u03b8 values of 6.51\u00b10.20, 11.62\u00b10.20, 13.05\u00b10.20, 15.07\u00b10.20, 17.12\u00b10.20, 23.28\u00b10.20, and 26.19\u00b10.20.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 97.0
- Lexical Diversity: 1.65116
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15452333', '15040481', '15042391', '14812095', '13767285']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7490755553850688
- 35 USC 102 Novelty (BERT): 0.5527966354919598
- Combined Prediction Score: 0.729447663395758
- Mean Citation Score: 324.98591
- Max Citation Score: 400.483
- Similarity Product: 357.94049429285525

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test